Publications by authors named "Brandon Swift"

Claim this Profile
L
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Gideon M Hirschfield, Christopher L Bowlus, David E J Jones, Andreas E Kremer, Marlyn J Mayo, Brandon Swift

Lancet Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat.
Fernando Carreño, Rashmi Mehta, Andrea Ribeiro de Souza, Jon Collins, Brandon Swift

CPT Pharmacometrics Syst Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease.
Zobair M Younossi, Michael J Estep, Sean Felix, Brian Lam, Sumanta Mukherjee, Brandon Swift

J Clin Exp Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat.
Eleni Karatza, Brandon Swift, Fernando Carreño, Sumanta Mukherjee, Linda Casillas

Liver Int· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Dose-Response-Time Analysis of Itch Reduction and Patient-Reported Tolerability Supports Phase III Dose Selection for Linerixibat.
Fernando Carreño, Eleni Karatza, Rashmi Mehta, Jon Collins, Daren Austin, Brandon Swift

Clin Pharmacol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor.
Konstantinos Stamatopoulos, Nena Mistry, Nikoletta Fotaki, David B Turner, Brandon Swift

Pharmaceutics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus.
Cynthia Levy, Stuart Kendrick, Christopher L Bowlus, Atsushi Tanaka, David Jones, Brandon Swift

Clin Gastroenterol Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.
Aline Barth, Caroline R Perry, Shaila Shabbir, Maciej J Zamek-Gliszczynski, Sebin Thomas, Brandon Swift

Clin Transl Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea.
Nicole E Scangarella-Oman, Mohammad Hossain, Caroline R Perry, Courtney Tiffany, Marcy Powell, Brandon Swift

Sex Transm Infect· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants.
Aline Barth, Mohammad Hossain, Caroline R Perry, Annette S Gross, Hirofumi Ogura, Brandon Swift

Clin Pharmacol Drug Dev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects.
Courtney Tiffany, Etienne F Dumont, Mohammad Hossain, Meenakshi Srinivasan, Brandon Swift

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and ADME Characterization of Intravenous and Oral [C]-Linerixibat in Healthy Male Volunteers.
Maciej J Zamek-Gliszczynski, David Kenworthy, David A Bershas, Mitesh Sanghvi, Adrian I Pereira, Brandon Swift

Drug Metab Dispos· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Conduct Considerations for First-in-Human Trials.
Jie Shen, Brandon Swift, Richard Mamelok, Samuel Pine, John Sinclair

Clin Transl Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care.
Brandon Swift, Lokesh Jain, Craig White, Vasu Chandrasekaran, Aman Bhandari

Clin Transl Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites.
Brandon Swift, Noelia Nebot, Jin Kyung Lee, Tianxiang Han, William R Proctor

Drug Metab Dispos· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
Brandon Swift, Wei Yue, Kim L R Brouwer

Pharm Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.
Brandon Swift, Nathan D Pfeifer, Kim L R Brouwer

Drug Metab Rev· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of seeding density and extracellular matrix on bile Acid transport and mrp4 expression in sandwich-cultured mouse hepatocytes.
Brandon Swift, Kim L R Brouwer

Mol Pharm· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of preclinical and clinical data with pharmacokinetic modeling and simulation to evaluate fexofenadine as a probe for hepatobiliary transport function.
Brandon Swift, Xianbin Tian, Kim L R Brouwer

Pharm Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers.
Xianbin Tian, Brandon Swift, Maciej J Zamek-Gliszczynski, Martin G Belinsky, Gary D Kruh

Drug Metab Dispos· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-spherical core in the explosion of supernova SN 2004dj.
Douglas C Leonard, Alexei V Filippenko, Mohan Ganeshalingam, Franklin J D Serduke, Weidong Li, Brandon J Swift

Nature· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis